Concepedia

Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

Geert O. Janssens, Saskia E. Rademakers, Chris H.J. Terhaard, Patricia Doornaert, Hendrik P. Bijl, Piet van den Ende, Alim Chin, Robert P. Takes, Remco de Bree, Ilse J. Hoogsteen,

Clinical Cancer Research · 2014 · 46 citations · 23 references

DOIFull text

Open access

Abstract

Results from the randomized phase III trial support previous observations that ARCON has the potential to correct the poor outcome of cancer patients with anemia (ClinicalTrials.gov number, NCT00147732).

References

23

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

Arlene A. Forastiere, Helmuth Goepfert, Moshe Maor et al. · New England Journal of Medicine · 2003 · 3.1K citations · Full text

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

Michael Henke, Roland Laszig, Christian Rübe et al. · The Lancet · 2003 · 1.2K citations

, , +9

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

Marianne Nordsmark, Søren M. Bentzen, Volker Rudat et al. · Radiotherapy and Oncology · 2005 · 930 citations

, , +9

Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma

Fabrice Denis, P. Garaud, É. Bardet et al. · Journal of Clinical Oncology · 2003 · 888 citations

Breast cancer trial with erythropoietin terminated unexpectedly

Brian Leyland‐Jones · The Lancet Oncology · 2003 · 472 citations

, , +5